Although not entirely precise in terms of the specific date, this menopause predictor is useful for optimizing preventative care for symptoms that disrupt the quality of life. It even has implications for reducing "the risk of diseases and conditions associated with loss of ovarian hormones."
MenoCheck is said to be the "first-ever FDA cleared, clinically validated blood test" of its kind. The menopause predictor is ideal for use by women between the ages of 42 to 62 as they enter the different stages of pre, peri and post menopause. The blood test measures one's levels of Anti-Müllerian Hormone (AMH) to estimate where people are. Moreover, knowledge of this will allow women to make better and more personalized decisions about their health, as well as their method of contraception as they go through menopause.
Image Credit: MenoCheck